The research body of the Union Health Ministry – the Indian Council of Medical Research (ICMR) – was awarded the International Kochon Prize 2017 on March 13, 2018 in New Delhi for its contribution to the national programme in Tuberculosis research.
The ICMR through its TB Consortium accelerated the efforts for research and development on the terminal disease in the country.
About TB Consortium
• The India TB Research Consortium (ITRC) was formed to fast-track and align efforts in TB research.
• It aims to achieve its goal by harnessing national and international expertise to advance technology as well as product development by delivering effective diagnostics, shorter drug regimens, efficacious vaccines along with newer interventions for TB control.
• The consortium is working with both public and private institutes to guide India’s research efforts towards the development of point-of-care diagnostics, shorter treatment regimens and an effective vaccine for Tuberculosis.
About the Kochon Prize
• The Kochon Prize is awarded annually by Stop TB Partnership to individuals or organizations that have made a significant contribution to combating tuberculosis.
• The prize is given by the Kochon Foundation, a non-profit foundation registered in the Republic of Korea.
• The award comprises prize money worth USD 65,000.
• The ICMR emerged the winner of the 2017 Kochon Prize from amongst 18 nominations.
The Union Government on March 13, 2018 launched a campaign to eradicate tuberculosis (TB) from India by 2025, five years ahead of the globally-set deadline.
Tuberculosis (TB) is one of India’s severest health crises. India has the highest TB burden in the world.
The World Health Organization declared Tuberculosis as an emergency 25 years ago. Over 10 million people contract the disease every year.